Citius Oncology Inc (CTOR)

1.07 +0.04 (+4.31%) USD  |  NASDAQ  |  Nov 05, 10:18
More

Citius Oncology Monthly Value at Risk (VaR) 5% (Since Inception)

Monthly Value at Risk (VaR) 5% (Since Inception) Chart

View Monthly Value at Risk (VaR) 5% (Since Inception) for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Monthly Value at Risk (VaR) 5% (Since Inception) Data

View and export this data back to 2024. Upgrade now.
Date Value
October 31, 2024 --
Date Value
September 30, 2024 --

Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years

Upgrade
Minimum
Sep 2024
Upgrade
Maximum
Oct 2024
Upgrade
Average
Upgrade
Median

Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks

Citius Pharmaceuticals Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade

Monthly Value at Risk (VaR) 5% (Since Inception) Related Metrics

Alpha (Since Inception) Upgrade
Beta (Since Inception) Upgrade
Annualized Standard Deviation of Monthly Returns (Since Inception) Upgrade
Max Drawdown (Since Inception) Upgrade